Compare JELD & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JELD | QTRX |
|---|---|---|
| Founded | 1960 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.7M | 160.0M |
| IPO Year | 2016 | 2017 |
| Metric | JELD | QTRX |
|---|---|---|
| Price | $1.47 | $2.49 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 2 |
| Target Price | $3.43 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,211,181,000.00 | $37,632,000.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | $2.06 | $10.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $0.93 | $2.40 |
| 52 Week High | $6.98 | $8.77 |
| Indicator | JELD | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 28.93 |
| Support Level | $1.25 | N/A |
| Resistance Level | $2.06 | $3.74 |
| Average True Range (ATR) | 0.15 | 0.29 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 38.39 | 6.69 |
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.